Polyarteritis nodosa-like vasculitis in association with minocycline use: a single-center case series

Tanaz A Kermani1, Erin K Ham, Michael J Camilleri

  • 1Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. kermani.tanaz@yahoomail.com

Abstract

Insights

Minocycline can cause polyarteritis nodosa (PAN)-like vasculitis, affecting skin or organs. Discontinuation of minocycline and immunosuppressants are key treatments for this drug-induced vasculitis.

Area of Science:

  • Rheumatology
  • Dermatology
  • Internal Medicine

Background:

  • Polyarteritis nodosa (PAN) is a rare systemic vasculitis.
  • Minocycline is an antibiotic used for various infections and inflammatory conditions.
  • Drug-induced vasculitis is an important differential diagnosis in patients presenting with vasculitic symptoms.

Purpose of the Study:

  • To investigate the clinical presentation, treatment strategies, and outcomes of patients developing PAN-like vasculitis.
  • To determine the association between minocycline therapy and the onset of PAN-like vasculitis.
  • To raise awareness among clinicians regarding this potential adverse effect of minocycline.

Main Methods:

  • Retrospective review of patients diagnosed with PAN-like vasculitis and minocycline use.
  • Inclusion criteria: age ≥18 years, minocycline use at symptom onset, exclusion of hepatitis B-associated PAN.
  • Diagnostic confirmation through angiography or tissue biopsy.

Main Results:

  • Nine patients (56% female, median age 30) were identified.
  • 56% presented with systemic involvement (e.g., renal artery microaneurysms, mesenteric vasculitis).
  • Diagnosis confirmed by histopathology (67%) or angiography (33%); minocycline was discontinued in all cases.

Conclusions:

  • Minocycline therapy can be associated with the development of PAN-like vasculitis, both cutaneous and systemic.
  • Clinicians should consider minocycline as a potential cause of medium-vessel vasculitis.
  • Atypical ANCA serologies or negative hepatitis B testing in the context of vasculitis should prompt consideration of drug-induced causes.

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...